Shi Na, Lan Lan, Luo Jiawei, Zhu Ping, Ward Thomas R W, Szatmary Peter, Sutton Robert, Huang Wei, Windsor John A, Zhou Xiaobo, Xia Qing
Department of Integrated Traditional Chinese and Western Medicine, Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu 610044, China.
IT Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
J Pers Med. 2022 Apr 11;12(4):616. doi: 10.3390/jpm12040616.
Current approaches to predicting intervention needs and mortality have reached 65-85% accuracy, which falls below clinical decision-making requirements in patients with acute pancreatitis (AP). We aimed to accurately predict therapeutic intervention needs and mortality on admission, in AP patients, using machine learning (ML).
Data were obtained from three databases of patients admitted with AP: one retrospective (Chengdu) and two prospective (Liverpool and Chengdu) databases. Intervention and mortality differences, as well as potential predictors, were investigated. Univariate analysis was conducted, followed by a random forest ML algorithm used in multivariate analysis, to identify predictors. The ML performance matrix was applied to evaluate the model's performance.
Three datasets of 2846 patients included 25 potential clinical predictors in the univariate analysis. The top ten identified predictors were obtained by ML models, for predicting interventions and mortality, from the training dataset. The prediction of interventions includes death in non-intervention patients, validated with high accuracy (96%/98%), the area under the receiver-operating-characteristic curve (0.90/0.98), and positive likelihood ratios (22.3/69.8), respectively. The post-test probabilities in the test set were 55.4% and 71.6%, respectively, which were considerably superior to existing prognostic scores. The ML model, for predicting mortality in intervention patients, performed better or equally with prognostic scores.
ML, using admission clinical predictors, can accurately predict therapeutic interventions and mortality in patients with AP.
目前预测干预需求和死亡率的方法准确率达到65%-85%,低于急性胰腺炎(AP)患者的临床决策要求。我们旨在使用机器学习(ML)准确预测AP患者入院时的治疗干预需求和死亡率。
数据来自三个AP患者入院数据库:一个回顾性数据库(成都)和两个前瞻性数据库(利物浦和成都)。研究了干预和死亡率差异以及潜在预测因素。进行单变量分析,随后在多变量分析中使用随机森林ML算法来识别预测因素。应用ML性能矩阵评估模型性能。
2846例患者的三个数据集在单变量分析中包括25个潜在临床预测因素。通过ML模型从训练数据集中获得了预测干预和死亡率的前十个确定的预测因素。干预预测包括非干预患者的死亡,验证准确率高(96%/98%),受试者操作特征曲线下面积(0.90/0.98)和阳性似然比(22.3/69.8)。测试集中的测试后概率分别为55.4%和71.6%,明显优于现有的预后评分。预测干预患者死亡率的ML模型与预后评分表现相当或更好。
使用入院临床预测因素的ML可以准确预测AP患者的治疗干预和死亡率。